India’s health financing overhaul is entering a more demanding phase: after improving cash control and cutting idle balances in the National Health Mission, the government now has to prove that faster fund flows translate into better care.
India NHM payment reform faces delivery test
That is the central challenge as the National Health Mission’s Single Nodal Agency system gives way to SNA-SPARSH, a just-in-time payment framework that has been mandatory for all centrally sponsored schemes since Nov. 1, 2025. The reform has already shown it can recover trapped money and speed releases, but the next test is whether India can move beyond tracking utilisation and start measuring service delivery, access and outcomes.
The evidence from Bihar and Odisha shows why the reform matters economically. The SNA model consolidated NHM money into one state-level account, closing thousands of downstream bank accounts that had made spending hard to trace and left funds sitting idle. Bihar recovered ₹675 crore in dormant balances, while Odisha consolidated ₹270 crore. Central transfers that once took two to three months in Bihar now take less than a month, while in Odisha the lag has fallen to under 15 days.
For a public health system, that is not just an accounting fix. Faster disbursement reduces the working-capital strain on districts and facilities, lowers the risk of service disruption and improves the state’s ability to deploy budgeted money during the fiscal year. In a sector where delays can mean delayed salaries, deferred procurement and missed immunisation or primary-care targets, liquidity has direct operational value.
But the reforms also expose a deeper weakness: India has been getting better at moving money, not necessarily at matching budgets to needs. Across 18 major states, administrative approvals for NHM spending have risen well beyond available resources, with the ratio of approvals to the actual resource envelope increasing from about 90% in 2014-15 to 153% in 2022-23. That gap forces administrators to protect committed costs such as wages and direct transfers, while squeezing discretionary spending on medicines, equipment and field operations.
The result is a system that can look efficient on paper while still under-delivering on services. The article’s underlying point is that input-based accountability — how much was released, booked or spent — is no longer enough. If fund utilisation remains the headline metric, agencies may still resort to workarounds such as booking advances as expenditures to satisfy targets, even when those moves say little about whether patients were treated or facilities were better supplied.
Digital capacity is another fault line. Once agencies are forced to draw funds electronically from a shared account, better-connected districts can move faster than remote ones with weaker systems and staff. That creates a risk that a reform meant to improve transparency could widen operational inequality unless smaller facilities get technical support, connectivity and some degree of liquid working capital for urgent needs.
For investors and policy watchers, the implications extend beyond health. SNA-SPARSH marks a broader shift in India’s public financial management toward tighter treasury control and lower float balances across central schemes. That should improve transparency and reduce idle government cash, but it also raises execution risk if accounting reforms outpace administrative capacity. The bull case is that cleaner cash management and real-time monitoring reduce leakage and improve delivery. The bear case is that overly rigid cash discipline, if not matched with better budgeting and data integration, could slow frontline services and create new bottlenecks.
The decisive question now is whether the finance ministry and health authorities can link payment systems with health management data, align approvals with actual resources and preserve enough flexibility at facility level to keep services running. If they can, India’s reform will become a model for converting budget discipline into better outcomes. If they cannot, it will remain an exercise in moving money more efficiently without proving that it did more good.
| Entity | Gains | Losses |
|---|---|---|
| Indian government | ▲tighter cash control | ▼execution complexity |
| State health agencies | ▲faster fund access | ▼weaker-budget states |
| Frontline facilities | ▲better transparency | ▼cash-flow bottlenecks |
| Patients/public health system | ▲potential service gains | ▼delays if approvals lag |


